Skip to content

Labor induction for premature rupture of membranes

Clinical trial on the effectiveness of oxytocin and sublingual administration of misoprostol in premature rupture of membranes before the onset of the active phase of labor in term pregnancies

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016042627615N1
Enrollment
86
Registered
2016-06-01
Start date
2016-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature rupture of membranes at term. Preterm spontaneous labour with preterm delivery

Interventions

Intervention 1: Intervention group: To received 10 units of oxytocin in 1 L of ringer's lactate solution or normal saline before labor contractions. Intervention 2: Control group: To received 25 µg of
Treatment - Drugs
Intervention group: To received 10 units of oxytocin in 1 L of ringer's lactate solution or normal saline before labor contractions.
Control group: To received 25 µg of misoprostol per 4 h for a maximum of six doses before labor contractions.

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Premature rupture of membranes after 37 weeks of gestation; not being in the active phase of labor; Bishop score below six; cephalic presentation (vertex); singleton pregnancy; no evidence of clinical or laboratory signs confirming chorioamnionitis before the intervention; confirmation of the normal status of the fetal heart. Exclusion criteria: Prior history of uterine scar; placenta previa; unstable status of the fetal heart; non-cephalic presentation; sensitivity to misoprostol; history of glaucoma in misoprostol users; contraindication to vaginal delivery (e.g., narrow pelvis and genital herpes), and 8) parity = 5.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Intervals between drug administration and labor induction,. Timepoint: Measurements the time of delivery contractions create (at least 3 contractions 30 to 45 seconds in 10 minutes) after intervention. Method of measurement: minutes.

Secondary

MeasureTime frame
Interval between cervical dilatation and fetal delivery. Timepoint: After cervical dilatation. Method of measurement: minutes.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Motamedi

Mashhad University of Medical Sciences

elham_m2003@yahoo.com+98 51 3762 6485

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026